BSEBoard Meeting6d ago · 26 Aug 2026, 04:55 pm
Approval of Material Related Party Transaction
Arvaya Healthcare Ltd · 524723
✦ AI SummaryRelated Party
Arvaya Healthcare Ltd has approved a material related party transaction for the acquisition of the copyright and intellectual property portfolio of DEFIB INSTITUTE OF HEALTH SOLUTIONS LLP for ₹10 Crores, funded from the company's rights issue proceeds.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern6/10
Regulatory Risk4/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Arvaya Healthcare Ltd - 524723 - Board Meeting Outcome for Acquisition Of Copyright And Intellectual Property Portfolio Of DEFIB INSTITUTE OF HEALTH SOLUTIONS LLP
Attachments (1)
📄pdf
Download →
48d4028e-b291-4306-a915-88d9b17f9ae4.pdf
View document text
August 26, 2026
The Secretary,
Listing Department
Bombay Stock Exchange Ltd
Phiroze Jeejeebhoy Towers,
Street, Mumbai – 400 001
Reference: Scrip Code: 524723/ ISIN: INE491D01017
Subject: Outcome of Meeting of Board of Directors of Arvaya Healthcare Limited (Formerly Known as
Bijoy Hans Limited) (“the Company”) in accordance with Regulation 30 of the SEBI (Listing Obligation
and Disclosure Requirements) Regulation, 2015 (“Listing Regulation”)
Respected Authorities,
Pursuant to the Regulation 30 of Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of
Directors of the Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) (“the Company”)
held today i.e. Wednesday, August 26, 2026 through video conferencing/other audio-visual has inter
alia, considered and approved the following amongst other items of agenda:
1. To consider and approve the Material Related Party Transaction with Navahmedi Solution
Private Limited for acquisition of its business undertaking (slump sale), including intellectual
property, assets and liabilities, out of rights issue proceeds.
Subsequent to the circulation of the original Agenda, the Board of Directors, with the unanimous
consent of all directors present at the meeting, revised the scope and structure of the proposed
transaction and discussed the following item:
1. Acquisition of Copyright and Intellectual Property Portfolio of DEFIB INSTITUTE OF HEALTH
SOLUTIONS LLP
The Board considered and approved the Material Related Party Transaction for the acquisition of the
Copyright and Intellectual Property (IP) portfolio of DEFIB INSTITUTE OF HEALTH SOLUTIONS LLP
(LLPIN: AAS-7091), comprising identified intellectual property assets, copyrights, and associated
rights, title, and interest therein, pursuant to a definitive Copyright & IP Assignment Agreement to be
executed between the Company and DEFIB INSTITUTE OF HEALTH SOLUTIONS LLP.
Key Details of the Transaction:
Structure: The transaction is structured strictly as an acquisition/assignment of the identified
Copyright and IP portfolio. It does not involve the acquisition of the entire business
undertaking of the LLP or a slump-sale acquisition of its business.
Consideration: The total consideration for the acquisition shall not exceed ₹10 Crores (Rupees
Ten Crores only), based on an independent valuation of the identified IP assets and associated
rights.
Mode of Funding: The consideration is proposed to be funded out of the proceeds of the
Company’s Rights Issue, subject to compliance with applicable provisions and the objects
specified in the Rights Issue documents.
Regulatory Approvals: Being a Material Related Party Transaction, the proposed transaction
is subject to compliance with the applicable provisions of the Companies Act, 2013, the rules
framed thereunder, and Regulation 23 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, including obtaining shareholder approval, if applicable.
Documentation & Governance: The draft Copyright & IP Assignment Agreement, valuation
report, and material terms were reviewed and recommended by the Audit Committee prior
to Board approval.
The meeting of Board of Directors of the Company commenced at 3.00 p.m. and concluded at 4:30 p.m.
We request you to kindly take the same on your record.
Thanking you,
Yours faithfully,
For and on Behalf of
Arvaya Healthcare Limited
(Formerly Known as Bijoy Hans Limited)
Kaushal Uttam Shah
Managing Director
DIN: 02175130
Place: Pune
Date: 26th August 2026
Place: Sangli